Specialty pharmaceuticals continue to be the fastest-growing class of medications in the US, making up 90 percent of the 2021 top sellers. The US healthcare system generates an estimated one zettabyte of data annually as patients undergo treatment while on specialty medication. How can manufacturers use this data to keep up with market demands?
Join our webinar. We’ll discuss:
-
How manufacturers can access quality data and services being provided, and how specialty pharmacies can provide higher quality data back to the manufacturer
-
How data-driven insights and analytics can help aggregate data to track patients across providers and pharmacies
-
Emerging trends and differentiation opportunities to stay ahead of the competition.
|
|
Nick Adams
Associate Director, Specialty Pharmacy Data, Takeda |
|
Rohit Pradhan
Associate Director Strategy Specialty Pharma, Indivior |
|
|
|
|
|
|
|
